~ Jun 08 Doctors Ignore Proven Alternative to Coronary Stents and Bypass Surgery - References
References
1. Zakliczynski M, Lekston A, Osuch M, et al. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease. Transplant Proc. 2007 Nov;39(9):2859-61.
2. Rajaram SS, Shanahan J, Ash C, Walters AS, Weisfogel G. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS. Sleep Med. 2005 Mar;6(2):101-6.
3. Braverman D. Heal Your Heart with EECP—The First Comprehensive Guide to Enhanced External Counterpulsation. Berkeley, CA:Celestial Arts;2005.
4. Sajja V, Dod H, Beto R, et al. An analysis of the efficacy and safety of enhanced external counterpulsation at West Virginia University Hospitals. WV Med J. 2007 May;103(3):10-2.
5. Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. J Am Coll Cardiol. 2007 Oct 16;50(16):1523-31.
6. Arora RR, Shah AG. The role of enhanced external counterpulsation in the treatment of angina and heart failure. Can J Cardiol. 2007 Aug;23(10):779-81.
7. Soran O. A new treatment modality in heart failure enhanced external counterpulsation (EECP). Cardiol Rev. 2004 Jan;12(1):15-20.
8. Yavari M, Montazeri HR. Effects of enhanced external counterpulsation on anginal symptoms and improvements in objective measures of myocardial ischaemia. Cardiovasc J Afr. 2007 May;18(3):154-6.
9. Soran O, Kennard ED, Kfoury AG, Kelsey SF. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). Am J Cardiol. 2006 Jan 1;97(1):17-20.
10. Pettersson T, Bondesson S, Cojocaru D, et al. One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation. BMC Cardiovasc Disord. 2006;628.
11. Zhang Y, He X, Chen X, et al. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation. 2007 Jul 31;116(5):526-34.
12. Soran O, Kennard ED, Bart BA, Kelsey SF. Impact of external counterpulsation treatment on emergency department visits and hospitalizations in refractory angina patients with left ventricular dysfunction. Congest Heart Fail. 2007 Jan;13(1):36-40.
13. Abbottsmith CW, Chung ES, Varricchione T, et al. Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial. Congest Heart Fail. 2006 Nov;12(6):307-11.
14. Cleland JG, Coletta AP, Freemantle N, et al. Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER. Eur J Heart Fail. 2005 Aug;7(5):931-6.
15. Feldman AM, Silver MA, Francis GS, et al. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol. 2006 Sep 19;48(6):1198-205.
16. Arora RR, Bergmann S. Effects of enhanced external counterpulsation (EECP) on myocardial perfusion. Am J Ther. 2007 Nov;14(6):519-23.
17. Shea ML, Conti CR, Arora RR. An update on enhanced external counterpulsation. Clin Cardiol. 2005 Mar;28(3):115-8.
18. Sinvhal RM, Gowda RM, Khan IA. Enhanced external counterpulsation for refractory angina pectoris. Heart. 2003 Aug;89(8):830-3.
19. DeMaria AN. A historical overview of enhanced external counterpulsation. Clin Cardiol. 2002 Dec;25(12 Suppl 2):II3-5.
20. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes.J Am Coll Cardiol. 1999 Jun;33(7):1833-40.
21. Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology. 2000;94(1):31-5.
22. Lawson WE, Hui JC, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol. 2000 Apr;23(4):254-8.
23. Holubkov R, Kennard ED, Foris JM, et al. Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris. Am J Cardiol. 2002 May 15;89(10):1182-6.
24. BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996 Jul 25;335(4):217-25.
25. Matsuo Y, Imanishi T, Hayashi Y, et al. The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease. Intern Med. 2008;47(3):127-34.
26. Vartanian SM, Sarkar R. Therapeutic angiogenesis. Vasc Endovascular Surg. 2007 Jun;41(3):173-85.
27. Springer ML. A balancing act: therapeutic approaches for the modulation of angiogenesis. Curr Opin Investig Drugs. 2006 Mar;7(3):243-50.
28. Van Craenenbroeck EM, Vrints CJ, Haine SE, et al. A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile. J Appl Physiol. 2008 Jan 24.
29. Sarto P, Balducci E, Balconi G, et al. Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure. J Card Fail. 2007 Nov;13(9):701-8.
30. Miller-Kasprzak E, Jagodzinski PP. Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp.(Warsz.). 2007 Jul;55(4):247-59.
31. Boos CJ, Blann AD, Lip GY. Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells. Methods Mol Med. 2007;139:211-24.
32. Casey DP, Conti CR, Nichols WW, et al. Effect of enhanced external counterpulsation on inflammatory cytokines and adhesion molecules in patients with angina pectoris and angiographic coronary artery disease. Am J Cardiol. 2008 Feb 1;101(3):300-2.
33. Available at: http://jap.physiology.org/cgi/reprint/00232.2003v1.pdf. Accessed March 12, 2008.
34. Bondke A, Buschmann IR, Bode C, Buschmann EE. Inducing collaterals in due time. Arteriogenesis as a preventive principle. Hamostaseologie. 2007 Dec;27(5):363-72.
35. Masuda D, Nohara R, Hirai T, et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography. Eur Heart J. 2001 Aug;22(16):1451-8.
36. Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001 Jan;37(1):93-9.
37. Zhang Y, He X, Chen X, et al. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation. 2007 Jul 31;116(5):526-34.
38. Conti CR. Current Nonpharmacologic Management of Coronary Artery Disease: Focus on External Counterpulsation. Curr Treat Options Cardiovasc Med. 2005 May;7(1):81-6.
39. Michaels AD, McCullough PA, Soran OZ, et al. Primer: practical approach to the selection of patients for and application of EECP. Nat Clin Pract Cardiovasc Med. 2006 Nov;3(11):623-32.
1. Zakliczynski M, Lekston A, Osuch M, et al. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease. Transplant Proc. 2007 Nov;39(9):2859-61.
2. Rajaram SS, Shanahan J, Ash C, Walters AS, Weisfogel G. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS. Sleep Med. 2005 Mar;6(2):101-6.
3. Braverman D. Heal Your Heart with EECP—The First Comprehensive Guide to Enhanced External Counterpulsation. Berkeley, CA:Celestial Arts;2005.
4. Sajja V, Dod H, Beto R, et al. An analysis of the efficacy and safety of enhanced external counterpulsation at West Virginia University Hospitals. WV Med J. 2007 May;103(3):10-2.
5. Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. J Am Coll Cardiol. 2007 Oct 16;50(16):1523-31.
6. Arora RR, Shah AG. The role of enhanced external counterpulsation in the treatment of angina and heart failure. Can J Cardiol. 2007 Aug;23(10):779-81.
7. Soran O. A new treatment modality in heart failure enhanced external counterpulsation (EECP). Cardiol Rev. 2004 Jan;12(1):15-20.
8. Yavari M, Montazeri HR. Effects of enhanced external counterpulsation on anginal symptoms and improvements in objective measures of myocardial ischaemia. Cardiovasc J Afr. 2007 May;18(3):154-6.
9. Soran O, Kennard ED, Kfoury AG, Kelsey SF. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). Am J Cardiol. 2006 Jan 1;97(1):17-20.
10. Pettersson T, Bondesson S, Cojocaru D, et al. One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation. BMC Cardiovasc Disord. 2006;628.
11. Zhang Y, He X, Chen X, et al. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation. 2007 Jul 31;116(5):526-34.
12. Soran O, Kennard ED, Bart BA, Kelsey SF. Impact of external counterpulsation treatment on emergency department visits and hospitalizations in refractory angina patients with left ventricular dysfunction. Congest Heart Fail. 2007 Jan;13(1):36-40.
13. Abbottsmith CW, Chung ES, Varricchione T, et al. Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial. Congest Heart Fail. 2006 Nov;12(6):307-11.
14. Cleland JG, Coletta AP, Freemantle N, et al. Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER. Eur J Heart Fail. 2005 Aug;7(5):931-6.
15. Feldman AM, Silver MA, Francis GS, et al. Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol. 2006 Sep 19;48(6):1198-205.
16. Arora RR, Bergmann S. Effects of enhanced external counterpulsation (EECP) on myocardial perfusion. Am J Ther. 2007 Nov;14(6):519-23.
17. Shea ML, Conti CR, Arora RR. An update on enhanced external counterpulsation. Clin Cardiol. 2005 Mar;28(3):115-8.
18. Sinvhal RM, Gowda RM, Khan IA. Enhanced external counterpulsation for refractory angina pectoris. Heart. 2003 Aug;89(8):830-3.
19. DeMaria AN. A historical overview of enhanced external counterpulsation. Clin Cardiol. 2002 Dec;25(12 Suppl 2):II3-5.
20. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes.J Am Coll Cardiol. 1999 Jun;33(7):1833-40.
21. Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology. 2000;94(1):31-5.
22. Lawson WE, Hui JC, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol. 2000 Apr;23(4):254-8.
23. Holubkov R, Kennard ED, Foris JM, et al. Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris. Am J Cardiol. 2002 May 15;89(10):1182-6.
24. BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996 Jul 25;335(4):217-25.
25. Matsuo Y, Imanishi T, Hayashi Y, et al. The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease. Intern Med. 2008;47(3):127-34.
26. Vartanian SM, Sarkar R. Therapeutic angiogenesis. Vasc Endovascular Surg. 2007 Jun;41(3):173-85.
27. Springer ML. A balancing act: therapeutic approaches for the modulation of angiogenesis. Curr Opin Investig Drugs. 2006 Mar;7(3):243-50.
28. Van Craenenbroeck EM, Vrints CJ, Haine SE, et al. A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile. J Appl Physiol. 2008 Jan 24.
29. Sarto P, Balducci E, Balconi G, et al. Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure. J Card Fail. 2007 Nov;13(9):701-8.
30. Miller-Kasprzak E, Jagodzinski PP. Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp.(Warsz.). 2007 Jul;55(4):247-59.
31. Boos CJ, Blann AD, Lip GY. Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells. Methods Mol Med. 2007;139:211-24.
32. Casey DP, Conti CR, Nichols WW, et al. Effect of enhanced external counterpulsation on inflammatory cytokines and adhesion molecules in patients with angina pectoris and angiographic coronary artery disease. Am J Cardiol. 2008 Feb 1;101(3):300-2.
33. Available at: http://jap.physiology.org/cgi/reprint/00232.2003v1.pdf. Accessed March 12, 2008.
34. Bondke A, Buschmann IR, Bode C, Buschmann EE. Inducing collaterals in due time. Arteriogenesis as a preventive principle. Hamostaseologie. 2007 Dec;27(5):363-72.
35. Masuda D, Nohara R, Hirai T, et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography. Eur Heart J. 2001 Aug;22(16):1451-8.
36. Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001 Jan;37(1):93-9.
37. Zhang Y, He X, Chen X, et al. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation. 2007 Jul 31;116(5):526-34.
38. Conti CR. Current Nonpharmacologic Management of Coronary Artery Disease: Focus on External Counterpulsation. Curr Treat Options Cardiovasc Med. 2005 May;7(1):81-6.
39. Michaels AD, McCullough PA, Soran OZ, et al. Primer: practical approach to the selection of patients for and application of EECP. Nat Clin Pract Cardiovasc Med. 2006 Nov;3(11):623-32.
Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.
While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.
- Life Extension - Life Extension Vitamins
- Metagenics
- MetaKids
- Weight Management
- Glucose Management
- Longevity & Wellness
- Antioxidants
- Body Care
- Bones
- Brain
- Chinese / Mushrooms
- Digestion
- Energy / Sports
- Health Concerns
- Heart / Circulation
- Hormone / Prostate
- Immune
- Inflammatory Factors
- Intimacy
- Liver / Urinary
- Phyto Extracts
- Powdered Supplements
- Seasonal / Respiratory
- Vitamins / Multivitamins / Aminos / Minerals
- Life Extension CoQ10
- ~Metagenics X
- New Products
- Relationship Consultant and Coach!
